Regional expression of the BCRP/ABCG2 transporter in term human placentas

被引:14
|
作者
Memon, Naureen [1 ]
Bircsak, Kristin M. [2 ]
Archer, Faith [1 ]
Gibson, Christopher J. [2 ]
Ohman-Strickland, Pamela [3 ]
Weinberger, Barry I. [1 ]
Parast, Mana M. [4 ]
Vetrano, Anna M. [1 ]
Aleksunes, Lauren M. [2 ,5 ]
机构
[1] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Pediat, New Brunswick, NJ 08901 USA
[2] Rutgers State Univ, Dept Pharmacol & Toxicol, Ernest Mario Sch Pharm, Piscataway, NJ 08854 USA
[3] Rutgers State Univ, Dept Biostat, Sch Publ Hlth, Piscataway, NJ 08854 USA
[4] Univ Calif San Diego, Dept Pathol, San Diego, CA 92035 USA
[5] Environm & Occupat Hlth Sci Inst, Piscataway, NJ 08854 USA
基金
美国国家卫生研究院;
关键词
BCRP; ABCG2; Transporter; Placenta; Housekeeping gene; CANCER RESISTANCE PROTEIN; LIMITS FETAL DISTRIBUTION; GENE-EXPRESSION; GROWTH RESTRICTION; MULTIDRUG-RESISTANCE; PREGNANT MOUSE; SAMPLING SITE; GLYBURIDE; SURVIVAL; TISSUES;
D O I
10.1016/j.reprotox.2013.11.003
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
The breast cancer resistance protein (BCRP, ABCG2) is an efflux transporter that removes xenobiotics that cross the placenta back to the maternal circulation, thereby limiting exposure of the fetus to drugs and chemicals. Currently, variability of BCRP expression within the placenta is not known. Ten placentas were collected from healthy women undergoing elective Cesarean sections at term. Villous samples were dissected in defined regions (medial, intermediate, and peripheral) and BCRP mRNA and protein were quantified. There were no regional differences in mRNA expression of housekeeping genes (GAPDH, RPL13a, PRL, 18S). GAPDH had the lowest correlation with BCRP Ct values and was used for BCRP mRNA normalization. No differences in placental BCRP mRNA and protein were observed among the sample sites (<20% variability). Sampling site does not affect the expression of BCRP, supporting the utility of single site sampling protocols to assess the interindividual regulation of this transporter in human placentas. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:72 / 77
页数:6
相关论文
共 50 条
  • [21] Functional assessment of ABCG2 (BCRP) gene polymorphisms to protein expression in human placenta
    Kobayashi, D
    Ieiri, I
    Hirota, T
    Takane, H
    Maegawa, S
    Kigawa, J
    Suzuki, H
    Nanba, E
    Oshimura, M
    Terakawa, N
    Otsubo, K
    Mine, K
    Sugiyama, Y
    DRUG METABOLISM AND DISPOSITION, 2005, 33 (01) : 94 - 101
  • [22] The Anthelmintic Triclabendazole and Its Metabolites Inhibit the Membrane Transporter ABCG2/BCRP
    Barrera, Borja
    Otero, Jon A.
    Egido, Estefania
    Prieto, Julio G.
    Seelig, Anna
    Alvarez, Ana I.
    Merino, Gracia
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (07) : 3535 - 3543
  • [23] The multidrug transporter ABCG2 (BCRP) is inhibited by plant-derived cannabinoids
    Holland, M. L.
    Lau, D. T. T.
    Allen, J. D.
    Arnold, J. C.
    BRITISH JOURNAL OF PHARMACOLOGY, 2007, 152 (05) : 815 - 824
  • [24] Interaction of probenecid with the Breast Cancer Resistance Protein transporter (BCRP/ABCG2)
    Merino, G.
    Real, R.
    Molina, A. J.
    Pulido, M. M.
    Prieto, J. G.
    Alvarez, A. L.
    LETTERS IN DRUG DESIGN & DISCOVERY, 2006, 3 (04) : 236 - 241
  • [25] Expression and functional activity of breast cancer resistance protein (BCRP, ABCG2) transporter in the human choriocarcinoma cell line bewo
    Ceckova, M
    Libra, A
    Pavek, P
    Nachtigal, P
    Brabec, M
    Fuchs, R
    Staud, F
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2006, 33 (1-2): : 58 - 65
  • [26] The ABC transporter BCRP/ABCG2 is a placental survival factor, and its expression is reduced in idiopathic human fetal growth restriction
    Evseenko, Denis A.
    Murthi, Padma
    Paxton, James W.
    Reid, Glen
    Emerald, B. Starling
    Mohankumar, K. M.
    Lobie, Peter E.
    Brennecke, Shaun P.
    Kalionis, Bill
    Keelan, J. A.
    FASEB JOURNAL, 2007, 21 (13): : 3592 - 3605
  • [27] Structure of the human multidrug transporter ABCG2
    Nicholas M. I. Taylor
    Ioannis Manolaridis
    Scott M. Jackson
    Julia Kowal
    Henning Stahlberg
    Kaspar P. Locher
    Nature, 2017, 546 : 504 - 509
  • [28] Structure of the human multidrug transporter ABCG2
    Taylor, Nicholas M. I. .
    Manolaridis, Ioannis
    Jackson, Scott M.
    Kowal, Julia
    Stahlberg, Henning
    Locher, Kaspar P.
    NATURE, 2017, 546 (7659) : 504 - +
  • [29] BCRP/ABCG2 EXPRESSION IS INVOLVED IN THE SENSITIVITY OF HCC CELLS TO SORAFENIB
    Chen, Y. J.
    Hsieh, Y. L.
    Chien, P. H.
    Chien, Y. F.
    Huang, W. C.
    ANNALS OF ONCOLOGY, 2013, 24 : 28 - 28
  • [30] ABCG2/BCRP: Specific and Nonspecific Modulators
    Pena-Solorzano, Diana
    Stark, Simone Alexandra
    Koenig, Burkhard
    Augusto Sierra, Cesar
    Ochoa-Puentes, Cristian
    MEDICINAL RESEARCH REVIEWS, 2017, 37 (05) : 987 - 1050